Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ramm Pharma Corp C.RAMM

Healthcare
RAMM Pharma Corp., through its wholly-owned operating subsidiaries, is engaged in the pharmaceutical and medical product business, and is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. With RAMM’s large scale cultivation facility, the combined operations are expected to provide for complete vertical... see more

Recent & Breaking News (CSE:RAMM)

RAMM Pharma Corp. Provides Update on Litigation

GlobeNewswire May 21, 2024

RAMM Pharma Corp. Announces Corporate Update

GlobeNewswire March 28, 2024

RAMM Pharma Corp. Announces Corporate Update

GlobeNewswire March 19, 2024

RAMM Pharma Corp. Announces Corporate Update

GlobeNewswire December 14, 2023

RAMM Pharma Corp. Announces Corporate Update

GlobeNewswire November 30, 2023

RAMM Pharma Corp. Announces Corporate Update.

GlobeNewswire November 17, 2023

RAMM Pharma Corp. Announces Corporate Update

GlobeNewswire October 11, 2023

Canadian Investment Regulatory Organization Trade Resumption - RAMM

Canada NewsWire September 28, 2023

RAMM Pharma Corp. Announces Clarification of its Corporate Update of September 12th

GlobeNewswire September 27, 2023

IIROC Trading Halt - RAMM

Canada NewsWire September 12, 2023

RAMM Pharma Corp. Announces Corporate Update

GlobeNewswire September 12, 2023

RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid

GlobeNewswire September 5, 2023

Ramm Pharma Announces Application for Management Cease Trade Order

GlobeNewswire February 13, 2023

RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer

GlobeNewswire December 9, 2022

RAMM Pharma (CSE:RAMM) closes deal with The Green Organic Dutchman (CSE:TGOD)

Caroline Egan  September 6, 2022

RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland

GlobeNewswire September 6, 2022

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

GlobeNewswire August 17, 2022

CSE Bulletin: Reinstatement - Ramm Pharma Corp. (RAMM)

Newsfile March 23, 2022

IIROC Trade Resumption - RAMM

Canada NewsWire March 23, 2022

CSE Bulletin: Suspension - Ramm Pharma Corp. (RAMM)

Newsfile March 7, 2022